Takeda Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the research and development, manufacture, sale and licensing of pharmaceuticals. The Company focuses on the main business areas of gastrointestinal diseases, rare diseases, plasma derivatives (immune diseases), oncology (cancer), and neuroscience (neuropsychiatric diseases). The Company focuses on three research and development areas: innovative biopharmaceuticals with the focus on gastrointestinal and inflammatory diseases, neuroscience, and oncology, plus plasma derivatives and vaccines. Most of the pharmaceuticals treat rare diseases in the focus disease areas and the plasma derivatives area. The Company operates in Japan, the United States, Europe, and China.
企業コードTAK
会社名Takeda Pharmaceutical Co Ltd
上場日Jun 21, 2085
最高経営責任者「CEO」Weber (Christophe)
従業員数47455
証券種類Depository Receipt
決算期末Jun 21
本社所在地4F
都市CHUO-KU
証券取引所NASDAQ OMX NASDAQ Basic NYSE
国Japan
郵便番号103-8668
電話番号81332782111
ウェブサイトhttps://www.takeda.com/
企業コードTAK
上場日Jun 21, 2085
最高経営責任者「CEO」Weber (Christophe)